Cross Country Healthcare, Inc. (CCRN) — Analyst outlook / Analyst consensus target is. Based on 14 analyst ratings, the consensus is bullish — 4 Buy, 10 Hold.
The consensus price target is $10.61 (low: $8.65, high: $14.00), representing an upside of 8.6% from the current price $9.77.
Analysts estimate Earnings Per Share (EPS) of $0.53 and revenue of $1.34B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.44 vs est $0.53 (missed -182.6%). 2025: actual $-2.93 vs est $0.10 (missed -3036.7%). Analyst accuracy: 0%.
CCRN Stock — 12-Month Price Forecast
$10.61
▲ +8.60% Upside
Average Price Target
Based on 14 Wall Street analysts offering 12-month price targets for Cross Country Healthcare, Inc., the average price target is $10.61, with a high forecast of $14.00, and a low forecast of $8.65.
The average price target represents a +8.60% change from the last price of $9.77.
Highest Price Target
$14.00
Average Price Target
$10.61
Lowest Price Target
$8.65
CCRN Analyst Ratings
Hold
Based on 14 analysts giving stock ratings to Cross Country Healthcare, Inc. in the past 3 months
EPS Estimates — CCRN
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$0.44
vs Est $0.53
▼ 221.0% off
2025
Actual –$2.93
vs Est $0.10
▼ 103.4% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect the company to turn profitable.
Revenue Estimates — CCRN
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $1.344B
vs Est $1.340B
▲ 0.3% off
2025
Actual $1.054B
vs Est $1.072B
▼ 1.7% off
Revenue Trend
Revenue has declined over the period shown. Analysts forecast significant revenue growth ahead.
